Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Nina Zdinjak

Court Dismisses Canopy's Cannabis Patent Infringement Lawsuit Against Jazz's GW Pharma

The U.S. District Court for the Western District of Texas dismissed a lawsuit filed by Canadian cannabis giant Canopy Growth (NASDAQ:CGC) against GW Pharmaceuticals on Feb. 25th. The lawsuit was initially filed in 2020, and since then, Britain’s GW Pharma was acquired by the biopharmaceutical company Jazz Pharmaceuticals (NASDAQ:JAZZ).

In the lawsuit, Canopy accused GW Pharma of unauthorized usage of Canopy’s intellectual property related to a CBD extraction method.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.